Approval · Notice of Compliance 5425 · 1994
PONSTAN: Notice of Compliance 5425
Issued March 1, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5425
- Date
- March 1, 1994
- Company
- Parke-Davis Division, Warner-Lambert Canada Inc.Scarborough, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PONSTAN | 02074761 | — |
Medicinal ingredients
- MEFENAMIC ACID 333 MG per CAP